David Corr PhD, MBA
Chief Executive Officer
Dave is passionate about the commercialization of excellent science and technology. Most familiar with hi-tech business in the Physical and Life Sciences, he founded and ran his Innovation Consulting business, DeCromo Consulting, supporting numerous commercialization projects in academia, SMEs, and Multi-nationals.
Dave held the role of CTO at EKF Diagnostics plc in which he was responsible for coordination and direction of the company’s Technology strategy across several subsidiaries and ensuring New Product outputs aligned to the Commercial and Marketing strategy of the business. As Vice-President of Fund Strategy at Intellectual Ventures, Dave was responsible for the fund’s Investment Plan and strategy, deploying over $300 million in capital to build the business’ patent portfolio across several industry sectors.
An inventor on over 70 patents, principally from his time at NTERA, as a co-founder, he built the business and guided several successful commercial and licensing programmes in addition to facilitating the raise of over $40 million in capital. Dave has a PhD in Chemistry from UCD and an MBA from the Smurfit School of Business.
Peter Kidney B.Comm., FCA.Dip IFRS
Chief Financial Officer
Mr Kidney is a founding shareholder and Director of HiberGene Diagnostics and has served the company as Chief Financial Officer since its incorporation in 2009.
From 2007 to 2010 Mr Kidney served as Chairman of Chariot Oil and Gas Ltd. and was instrumental in raising app. $100 million and listing the company shares on the UK AIM market in 2008. Mr Kidney was a founding Director of Providence Resources Plc from 1997 to 2010, an AIM listed Oil and Gas exploration and production company where he was also Chairman of its Audit Committee.
Mr Kidney’s career also includes 16 years in the roles of Chief Financial Officer and subsequently CEO at mining company ARCON International Resources Plc, which had a full list on the London & Irish Stock Exchanges. It was during his tenure at ARCON that the Galmoy mine was developed and brought into production, following which the company was sold for approx. $123 million. While at ARCON, Mr Kidney also held the position of Chairman at the Irish Mining Association group (IMEG) between 2004 and 2006. Mr Kidney is a Chartered Accountant with a Diploma in IFRS (with distinction) and his B. Comm. was earned at University College Dublin, Ireland.
Gary Keating Diploma in Industrial Studies, B.Sc. (Hons), Ph.D.
Chief Technology Officer
Dr. Keating joined HiberGene Diagnostics as Chief Technology Officer in October 2014. He has 15 years of technical and management experience in the in-vitro diagnostics industry, with a strong record in the planning and delivery of new product development projects and complex technology transfer.
Prior to joining HiberGene, Dr. Keating served as R&D Manager and subsequently Molecular Technology Manager, at DiaSorin Ireland where he was instrumental in the development and 2012 launch of DiaSorin’s Liaison Iam molecular diagnostic system and infectious disease assays. Previously, Dr. Keating served at Biotrin Ltd from 2006 until their acquisition by DiaSorin in 2008, overseeing the transition of the R&D department from a group focused on older immunoassay technology to a team of molecular diagnostic specialists.
From 2000 to 2006 Dr. Keating held a number of positions at Abbott Diagnostics in Sligo: as Transfer Manager he was directly responsible for the successful technology transfer of CE-marked automated immunoassay products from the US as part of a major corporate project which significantly increased plant size and headcount. Dr. Keating earned his Diploma in Industrial Studies and B.Sc. with honours at the University of Ulster, Jordanstown and completed his Ph.D. focused on the design of novel biosensor-based immunoassays at Dublin City University.